Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$499.74 -9.01 (-1.77%)
At close: Oct 16, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Share-based Compensation (2009 - 2026)

Updated

Vertex Pharmaceuticals (VRTX) posted Share-based Compensation of $170.2 million for Q2 2026, up 1.7% from $167.3 million a year earlier and up 2.3% from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Share-based Compensation (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Vertex Pharmaceuticals was $689.1 million, up 0.5% year-over-year; for FY2025, it was $685.9 million, down 1.8% from FY2024.

  • Annual Share-based Compensation shows a five-year compound annual growth rate of 9.8% (FY2020 to FY2025).
  • In prior years, Vertex Pharmaceuticals' Share-based Compensation was $698.5 million in FY2024 (+20.2%), $581.2 million in FY2023 (+18.3%), $491.3 million in FY2022 (+11.3%) and $441.4 million in FY2021 (+2.8%).
  • Quarterly Share-based Compensation has run from a low of $103 million in Q3 2021 to a high of $208.6 million in Q4 2023 over five years.
  • On a year-over-year basis, Share-based Compensation increased in five of the last eight quarters, with growth averaging 2.2%.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was Q4 2023, with growth of 87.1%; the weakest was Q4 2024, with a decline of 19.6%.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $166.4 million (Q1 2026), $157.6 million (Q4 2025) and $194.9 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 458.00 Mn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 166.00 Mn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn -
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn -
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 231.00 Mn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 249.00 Mn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn 170.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 170.20 Mn
Mar 31, 2026 166.40 Mn
Dec 31, 2025 157.60 Mn
Sep 30, 2025 194.90 Mn
Jun 30, 2025 167.30 Mn
Mar 31, 2025 166.10 Mn
Dec 31, 2024 167.80 Mn
Sep 30, 2024 184.60 Mn
Jun 30, 2024 154.20 Mn
Mar 31, 2024 191.90 Mn
Dec 31, 2023 208.60 Mn
Sep 30, 2023 130.90 Mn
Jun 30, 2023 119.30 Mn
Mar 31, 2023 122.40 Mn
Dec 31, 2022 111.50 Mn
Sep 30, 2022 135.60 Mn
Jun 30, 2022 113.90 Mn
Mar 31, 2022 130.30 Mn
Dec 31, 2021 118.60 Mn
Sep 30, 2021 103.00 Mn
API Access

Vertex Pharmaceuticals Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=VRTX&period=max&api_key=YOUR_API_KEY